Clinical Trials Browser

Phase 2 × OTHER × vinflunine × Clear all

NCT00545766 2021-12-16

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

41 enrolled 11 charts

Prostatic Neoplasms

NCT02057913 2020-07-23

VinCaP

Phase 2 Completed

Penile Neoplasms

NCT02665039 2019-10-08

VINGEM

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT01529411 2019-04-04

MAJA

Phase 2 Completed

Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Phase 2 Terminated

18 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00450515 2016-12-06

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male

NCT00284180 2013-08-09

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Phase 2 Completed

32 enrolled 6 charts

Breast Neoplasms

NCT00284154 2013-03-13

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

Phase 2 Completed

51 enrolled 10 charts

Lung Neoplasms, Recurrence, Carcinoma, Small Cell

NCT00251446 2012-05-11

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung